检索规则说明:AND代表“并且”;OR代表“或者”;NOT代表“不包含”;(注意必须大写,运算符两边需空一格)
检 索 范 例 :范例一: (K=图书馆学 OR K=情报学) AND A=范并思 范例二:J=计算机应用与软件 AND (U=C++ OR U=Basic) NOT M=Visual
作 者:陈素婷[1]
机构地区:[1]江西省萍乡市人民医院呼吸科,江西萍乡337000
出 处:《中国当代医药》2018年第1期44-46,共3页China Modern Medicine
摘 要:目的观察呼吸操及肌力训练联合支气管舒张药治疗中重度慢性阻塞性肺疾病的效果。方法选取我院2016年2月~2017年4月收治的77例中重度慢性阻塞性肺疾病患者,参照组33例患者采取雾化吸入支气管舒张药物治疗,研究组44例患者在参照组基础上联合应用呼吸操、肌力训练治疗。比较两组的临床效果。结果治疗后,研究组患者的总有效率为93.2%,生存质量评分为(95.41±1.23)分,参照组分别为72.7%、(86.92±7.42)分,两组患者的上述指标差异有统计学意义(P<0.05),研究组患者的FEV1%pred、PaCO_2、PaO_2的改善程度优于参照组(P<0.05)。结论中重度慢性阻塞性肺疾病患者应用支气管舒张药物、呼吸操以及肌力训练治疗,对改善患者的肺功能,提高其生存质量具有重要意义。Objective To observe the effect of respiratory exercise,muscle strength exercise combined with bronchial di- astolic drug treating moderate-severe chronic obstructive pulmonary disease.Methods From February 2016 to April 2017,77 patients with moderate-severe chronic obstructive pulmonary disease treated in our hospital were selected.In the reference group,33 patients were treated by aerosol inhalation of bronchial diastolic drug.In the research group,44 patients were given the respiratory exercise and muscle strength exercise on the basis of the reference group.The clini- cal effect between the two groups was compared.Results After treatment,the total effective rate was 93.2% and the score of life quality was (95.41 ±1.23) points in the research group while in the reference group,it was 72.7% and (86.92±7.42) points respectively,and there was a statistical difference of above-mentioned indexes between the two groups (P〈O.05).The improvement degree of FEV1%pred,PaCO2 and PaO2 in the research group were better than those in the reference group (P〈0.05).Conelusion For patients with moderate-severe chronic obstructive pulmonary diseases, application of bronchial diastolic drug,respiratoryexercise,and muscle strength exercise is of great significance on im- provement of pulmonary function as well as the life quality.
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...
正在链接到云南高校图书馆文献保障联盟下载...
云南高校图书馆联盟文献共享服务平台 版权所有©
您的IP:216.73.216.117